Important NEW developments regarding the clobazam (Frisium) shortage: Suzanne Nurse, Chair, Canadian Epilepsy Alliance Drug Shortages Committee Clobazam is in short supply, but is still available at some pharmacies. If inventories have become low or depleted at your pharmacy, ask your pharmacist to recheck the status of clobazam and Frisium with their suppliers. The next few days will continue to be challenging for people, due to the depletion of the clobazam inventory at many pharmacies. However, some replenishment of generic clobazam (Apo-clobazam, Apotex Inc.) is expected at the end of this week or early next week. The new stock will be spread across the country with limited amounts to individual pharmacies. A second replenishment of …show more content…
Health Canada will be working with pharmaceutical manufacturers and other stakeholders to monitor status over the summer. I take clobazam, what should I do? · Continue to take clobazam as indicated by your healthcare provider o do not skip doses o do not take less than the prescribed amount o do not make any changes in your treatment without medical advice · Develop a management plan with your pharmacist and your healthcare provider in case clobazam is not available. You can share the following clinical management suggestions with your healthcare team: · If your pharmacy is unable to refill your prescription – ask your pharmacist o have they exhausted all avenues to try and find clobazam for you? o have they searched for generic clobazam and brand name clobazam (Frisium)? · If it is necessary to make changes to your treatment plan due to the shortage o ask for a copy of the new treatment instructions in writing o go over the information with your pharmacist o ask your pharmacist to explain the information again if the instructions are not
PRN medication can be ordered on a repeat prescription, along with any other medication the service user may be taking. However care must be taken to check existing stock levels in order to avoid the over-ordering of medication. If stock levels are sufficient enough to last until the next order date they should be left off the repeat order.
As a pharmacist I could calmly and as kindly as possible explain that because the prescription is a controlled medication I would not be able to give them a few days emergency supply. I would recommend that they visit the closest urgent care facility to acquire this prescription.
As a critical care nurse the concern with medication shortages really hits home. In my current practice I have been asked by our hospital pharmacy to decrease the amount of Ativan given to a patient because the supply was low and they did not have any more to restock our omnicell. I am unsure the reason behind this particular shortage, but several other drugs we currently use are in low supply, most importantly epinephrine. Epinephrine is a life-saving medication, not only for supply on our code carts for cardiac arrest, but available in injection form for people with severe allergies. The shortage affects everyone, from oncology patients to cardiac patients. Recent policy changes have been made in order to correct the major shortages to help keep these life-saving drugs on the market and available to the people that need them.
In period five, we introduced the line extension Allright; a 12-Hr muli-symptom relief capsule. We decided this extension would be successful, as the allergy market is very small and had an entrenched competitor. Therefore, while we were aware of potential cannibalization, we believed that the targeted market (retirees, empty nesters, and young singles) would have sufficient demand for our product. We also reasoned that this target was far enough removed from Allround’s to gain additional market share without taking any from Allround. However, this was not the case, as cannibalization was a pressing issue. Market share was gained at the expense of Allround.
Most consumables used in healthcare have a use by date and will need to be replaced, at haxby we check stock weekly to make sure it is all in date. some pieces of equipment/drugs can be ruined by temperature or sunlight.
Defining what constitutes a drug shortage is an important first step. The Food and Drug Administration (FDA) and American Society of Health-System Pharmacists (ASHP) are considered the authorities on current prescription drug shortages. The FDA provides a list of drugs that are in short supply. The FDA gathers information about drug shortages in a variety of ways. In the case of drugs that are by legislation deemed to be medically necessary, manufactures are required by law to report to the FDA any foreseen shortages or planned discontinuation of these medications (Dill & Ahn, 2014, p.1410). Additionally, sometimes other medications in short supply are voluntarily reported to the FDA. The FDA does monitor the ASHP website for information about potential shortages. The ASHP, located at the University of Utah, also keeps on their website an up to date list of all prescription drug shortages. The ASHP gathers information from manufactures who voluntarily report, practitioners, patients, and pharmacy industry representatives (Dill & Ahn, 2014, p. 1410). It is important to note, the two lists have marked dissimilarities due to differences in the criteria used to define a drug in short supply, and method used to gather data (Figures 1&2). While both organizations have valid reasons for their inclusion criteria, having two lists, with such conflicting
the care of the patient is better served at another facility that can provide certain services
The Web Portal could also be expanded to provide outside vendor services such as, Just in Time pharmaceutical replenishment and inventory updates. Just in Time pharmaceutical replenishment will allow the hospital to automatically replenish stock and optimize inventory. The hospital will have to grant access to its database to companies similar to Just in Time, but the rewards for the hospital will be phenomenal. The hospital can cross references the prescription company’s database to ensure that no other medication the patient is taking will have complications for the patients or adverse effects. The system could also recommend alternatives to the prescribe medications to even further
The National Institutes of Health found that “manufacturing problems and business decisions had caused twenty-three percent of drug shortages.” The FDA has currently listed sixty-two drugs undergoing a shortage. Forty-three of those are hospital injections for pediatrics.
According to the patient, he has an appointment with Wheeler Clinic, referring to his prescriber Laura kennedy on 01/24/2017 to have his scripts refill. The patient says, he has to see his prescriber monthly because she, referring to the prescriber, does not place an order for refills because she wants her patient to see her for updates of their well-being. Addressing the Nexium DR, the patient is prescribed through his PCP. The patient says, " I bought in the medication
Would you prefer to have one if you need it? Or would you prefer to stop treatment? Why? Or Why not? P 1.
Is the idea consistent with how they speak to Patients about the conditions and treatment options?
“Effective January 1, 2012, the Company changed its methods of accounting for prescription drug inventories in the Retail Pharmacy Segment. Prior to 2012, the Company valued prescription drug inventories at the lower of cost or market on a first-in, first-out (“FIFO”) basis in retail pharmacies using the retail inventory method and in distribution centers using the FIFO cost method.” (Annual Report Archive)
In order to alleviate the long wait times, the clinic either needs to hire more physicians at an additional cost of $55,000 each, or the clinic needs to find ways to increase the utilization of the nurse practitioners to reduce the burden carried by the physicians. In light of the comparatively high cost of hiring physicians as compared with the cost of increasing the utilization of the nurse practitioners, we recommend taking the following steps instead of simply hiring additional physicians.
Ratios aside, the patent of its older product (mainly Zyprexa) will expire in 2011. However, the increased in the newer products that accounts for total sales has increased to 24% from 18% in